MIB Agents OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors”
Robbie Majzner, MD
Assistant Professor of Pediatrics
Stanford University School of Medicine
Dr. Majzner is an Assistant Professor of Pediatrics at Stanford University School of Medicine. After graduating with a BA from Columbia University, he attended Harvard Medical School, where he developed an interest in pediatric oncology. He completed his residency at NY Presbyterian-Columbia and fellowship in pediatric hematology-oncology at Johns Hopkins and the National Cancer Institute. During his fellowship, he cared for some of the first pediatric patients to receive CD19 chimeric antigen receptor (CAR) T cells. Witnessing the success of CAR T cells in these patients drove Dr. Majzner to the laboratory, where he focuses on developing immunotherapies for children with incurable solid tumor cancers. His laboratory work aims to generate highly efficacious CAR T cells and to find new immunotherapeutic strategies to treat pediatric cancer.
Our panel today includes 2021 MIB Junior Board Members Charlotte Murdoff Mia Sandino, and Amy Woodchecke, a childhood cancer survivor and pediatric oncology Physician’s Assistant. I am your host, Ann Graham President of MIB Agents.
Amy Woodcheke, BS, MHS, PA-C
Charlotte Murdoff, 2021 MIB Junior Board Member & OsteoWarrior
Mia Sandino, 2021 MIB Junior Board Member & OsteoWarrior
Hosted By Ann Graham, MIB Agents President & OsteoWarrior
Next week we will talk with Dr. Brian Van Tine of Washington University in St. Louis on Osteosarcoma Tumor Metabolism.
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org